Release Date: 30/09/15 08:33 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 185.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%